References:

[1]李祥山.分析糖皮质激素药理特性及其药物制剂的研究进展[J].临床医药文献电子杂志,2019,6(95):198.
[2] Iida S, Ichinohe T, Shinagawa A, et al. Safety and efficacy of daratumumab in combination with bortezomib and dexamethasone in Japanese patients with relapsed or refractory multiple myeloma[ J] . Int J Hematol, 2018, 107( 4) :460 -467.
[3]张玲.地塞米松致呃逆36例临床分析[J].中国冶金工业医学杂志,2018,35(1):83-84.
[4]宋晓霓,侯祖超,任利杰,等.静脉注射地塞米松致呃逆1例[J].西南军医,2018,20(5):601.
[5]杜倩,王元,韩宝杰.针灸治疗中风后呃逆的研究进展[J].中国民族民间医药,2017,26(12):59-62.
[6]姜泊.胃肠病学[M].北京:人民卫生出版社,2015:96-97.
[7] Go SI, Koo DH, Kim ST, et al. Antiemetic Corticosteroid Rotation from Dexamethasone to Methylprednisolone to Prevent Dexamethasone - Induced Hiccup in Cancer Patients Treated with Chemotherapy: A Randomized, Single - Blind, Crossover Phase III Trial[ J] . Oncologist, 2017,22( 11) :1354 -1361.
[8] Giles AJ, Hutchinson MND, Sonnemann HM, et al. Dexamethasone - induced immunosuppression: mechanisms and implications for immunotherapy [ J] . J ImmunotherCancer,2018,6( 1) :51.
[9]张梦怡,曾卫强,劳海燕.鼻咽癌患者口服地塞米松片致顽固性呃逆1例[J].海峡药学,2018,30(2):276.
[10] Rouse S, Wodziak M. Intractable Hiccups[ J] . Curr Neurol Neurosci Rep,2018,18( 8) :51.
[11]王贝,姜淑君.顽固性呃逆的中医治疗进展[J].中西医结合研究,2019,11(6):316-318.
[12] Hou XF, Wang XJ, Zhang JB, et al. Summary and core technique on the origin and evolution of reinforcing - reducing manipulation achieved by lifting and thrusting the needle[ J] . Zhongguo Zhen Jiu,2019,39( 7) :729 -33.
[13]戚思,李宁.揿针的历史沿革及作用机制[J].中医临床研究,2019,11(11):34-36.
[14]毛林焕.近3年揿针临床研究进展[J].内蒙古中医药,2017,36(12):151-152.
[15]梁芳妮,马燕辉,刘红玉,等.揿针主要临床应用研究进展[J].中医药导报,2019,25(11):122-124.
[16]唐亚,林思睿,吴巧凤,等.皮内针的优势病种及运用前景分析[J].医学信息,2019,32(6):32-34.
[17]徐兆山,杨森林,卢秀玲,等.揿针与浅刺法理论及治疗脾胃系疾病概况[J].实用中医内科杂志,2019,33(2):75-77.
[18]岳华,慕常松.急治打嗝验方[J].中国民间疗法,2020,28(12):54.
[19]谭瑛.穴位按压并揿针治疗脑卒中患者顽固性呃逆的疗效对比观察[J].实用医院临床杂志,2017,14(4):234-235.
[20]赵琰,仕军伟,郑昊.揿针埋针配合护理治疗中风后呃逆随机对照试验[J].中国中医药现代远程教育,2019,17(18):97-99.